WaveMan · Form 4
Trigilio Jeffrey insider trades
> Search tickers & screens ⌘K
LIVE

Trigilio Jeffrey insider trades

Trigilio Jeffrey has filed 23 Form 4s with the SEC that we hold, for Cullinan Therapeutics, Inc. (CGEM) (Chief Financial Officer) and XOMA Royalty Corp (XOMA) (Chief Financial Officer). Across all of them we count 0 purchases worth $0 and 13 sales worth $689.7K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 9,513 shares of Cullinan Therapeutics, Inc. worth $274.5K, dated 2021-09-08. The first filing on our record is dated 2021-09-09 and the latest 2026-07-14.

Cullinan Therapeutics, Inc. (CGEM)

Chief Financial Officer · 18 filings · 13 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-09-08S, sale reported on Form 49,513$274.5K2021-09-09
2021-09-08S, sale reported on Form 45,487$152.7K2021-09-09
2021-10-15S, sale reported on Form 48,000$200.0K2021-10-18
2023-03-20S, sale reported on Form 4399$4.5K2023-03-27
2023-04-12S, sale reported on Form 4318$3.2K2023-04-14
2023-04-18S, sale reported on Form 4398$4.3K2023-04-20
2023-05-12S, sale reported on Form 4347$3.0K2023-05-16
2023-05-18S, sale reported on Form 4399$3.5K2023-05-19
2023-06-12S, sale reported on Form 4319$4.2K2023-06-14
2023-06-20S, sale reported on Form 4399$5.2K2023-06-21
2023-12-12S, sale reported on Form 41,926$15.0K2023-12-13
2023-12-18S, sale reported on Form 4398$3.3K2023-12-20
2023-12-21S, sale reported on Form 41,920$16.3K2023-12-22

XOMA Royalty Corp (XOMA)

Chief Financial Officer · 5 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1838671) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms